Domain Therapeutics

Domain Therapeutics Further Strengthens Leadership Team With Appointment of Sean A. MacDonald as Chief Business Officer

STRASBOURG, France & MONTREAL & BOSTON–(BUSINESS WIRE)–Domain Therapeutics (“Domain” or “the Company”), a clinical-stage global biopharmaceutical company developing innovative drug candidates in immuno-oncology targeting G Protein-Coupled Receptors (GPCRs), today announces the appointment of Sean A. MacDonald as its Chief Business Officer (CBO) and member of the executive management team. In his new position, Sean will lead corporate strategy and business development bringing broad and deep … Continue reading Domain Therapeutics Further Strengthens Leadership Team With Appointment of Sean A. MacDonald as Chief Business Officer

Gilead Sciences

Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

— Gilead Adds Seladelpar to Portfolio, a PPARδ Agonist for the Treatment of Primary Biliary Cholangitis (PBC) with FDA Priority Review and Anticipated U.S. Approval in Third Quarter of 2024 — — Seladelpar Phase 3 Data Demonstrates a Best-in-Disease Profile for Second-Line PBC — — Acquisition Expands Gilead’s Long-Standing Commitment to Patients with Liver Diseases — February 12, 2024 08:30 AM Eastern Standard Time FOSTER … Continue reading Gilead Sciences Expands Liver Portfolio With Acquisition of CymaBay Therapeutics

Sanofi

Press Release: Peer support, flexible work arrangements, salary for a year: Sanofi launches global program for employees affected by cancer and critical illnesses

February 05, 2024 02:00 ET| Source: Sanofi – Aventis Groupe Peer support, flexible work arrangements, salary for a year: Sanofi launches global program for employees affected by cancer and critical illnesses Paris, February 5, 2024. Sanofi today launches ‘Cancer & Work: Acting Together’, a global program to support Sanofi employees whose lives are impacted by cancer and other critical illnesses. This program covers all Sanofi employees in … Continue reading Press Release: Peer support, flexible work arrangements, salary for a year: Sanofi launches global program for employees affected by cancer and critical illnesses

APLANTEX

Frederick Perrault Joins Aplantex’s Board of Directors

MONTRÉAL–(BUSINESS WIRE)–Mr. Patrick Charest, B. Sc., P. Eng., CEO of Aplantex, is pleased to announce the arrival of Mr. Frédérick Perrault, CPA, CA, M. Sc., as an investor, strategic advisor, and member of the company’s board of directors. “We are very proud to welcome this expert in financial, strategic, and governance management focused on innovation and growth,” said Mr. Charest. “His valuable contribution will help … Continue reading Frederick Perrault Joins Aplantex’s Board of Directors

CDISC

CDISC Names Chris Decker President and CEO

AUSTIN, Texas–(BUSINESS WIRE)–CDISC announces industry veteran Chris Decker is joining the organization as its new President and Chief Executive Officer effective January 2, 2024, succeeding Dave Evans who will be transitioning into retirement after decades of outstanding service to CDISC. Chris is recognized industry wide as a leading technology and standards expert for designing, developing, and implementing complex process and technology solutions. He brings years … Continue reading CDISC Names Chris Decker President and CEO